Please use this identifier to cite or link to this item: doi:10.22028/D291-30787
Title: High prevalence of ESBL-producing Klebsiella pneumoniae in clinical samples from central Côte d'Ivoire
Author(s): Müller-Schulte, Eloise
Tuo, Marie Nonfra
Akoua-Koffi, Chantal
Schaumburg, Frieder
Becker, Sören
Language: English
Title: International Journal of Infectious Diseases
Volume: 91
Startpage: 207
Endpage: 209
Publisher/Platform: Elsevier
Year of Publication: 2019
Free key words: Africa
Antibiotics
Antimicrobial resistance
Bacteria
Diagnosis
Enterobacterales
Sepsis
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Objectives: Infections caused by multidrug-resistant Enterobacterales pose a significant challenge to clinical patient care, particularly in resource-constrained settings where epidemiological data on antimicrobial resistance are scarce. The aim of this study was to determine the prevalence of extended spectrum beta-lactamase-(ESBL)-producing Klebsiella pneumoniae among clinical samples from a teaching hospital in Bouaké, central Côte d’Ivoire. Methods: Clinical specimens were collected from sterile and non-sterile body sites and were subjected to microbiological diagnostics (April 2016-June 2017). The antimicrobial susceptibility patterns of K. pneumoniae were analysed using automated resistance testing and double-disk diffusion to test for ESBL production. Multiplex PCR was carried out to determine the presence of the resistance-conferring genes blaCTX-M, blaSHV and blaTEM. Results: A total of 107 isolates were included, most of which were obtained from bloodstream (39%; n = 42) and urinary tract infections (39%; n = 42). Among all K. pneumoniae isolates, 84% (n = 90) were ESBL producers, many of which were also not susceptible to sulfonamides (99%), quinolones (81%) and aminoglycosides (79%). The majority of ESBL-producing strains harboured all three investigated bla genes. Conclusion: The high prevalence of ESBL-producing K. pneumoniae in clinical isolates from Côte d’Ivoire calls for revised empirical treatment regimens in critically ill patients with suspected Gram-negative infections, and the establishment of antimicrobial resistance surveillance systems.
DOI of the first publication: 10.1016/j.ijid.2019.11.024
Link to this record: urn:nbn:de:bsz:291--ds-307879
hdl:20.500.11880/29052
http://dx.doi.org/10.22028/D291-30787
ISSN: 12019712
Date of registration: 24-Apr-2020
Faculty: M - Medizinische Fakultät
Department: M - Infektionsmedizin
Professorship: M - Prof. Dr. Dr. Sören Becker
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
PIIS1201971219304643.pdfHigh prevalence289,99 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons